Marine compound shows promise against brain-eating amoeba infection

Researchers isolated a compound from marine sources that inhibits the pathogen causing primary amebic meningoencephalitis, a nearly always fatal infection. The finding is preclinical and unverified in humans, but offers a potential therapeutic avenue for a disease with no effective treatment. Significance lies in the scientific breakthrough, not immediate market impact.

AI disclosure: Model-written summary of the source, not a verified fact. Check the sources. How Mosaic works